Compare HUMA & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUMA | SEVN |
|---|---|---|
| Founded | 2004 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.7M | 167.9M |
| IPO Year | 2020 | 2008 |
| Metric | HUMA | SEVN |
|---|---|---|
| Price | $0.44 | $6.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $1.63 | ★ $9.55 |
| AVG Volume (30 Days) | ★ 5.7M | 196.9K |
| Earning Date | 11-11-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 18.15% |
| EPS Growth | ★ 79.37 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | $2,038,000.00 | ★ $29,383,000.00 |
| Revenue This Year | $72.32 | $18.67 |
| Revenue Next Year | $518.79 | $12.98 |
| P/E Ratio | ★ N/A | $32.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.34 | $5.98 |
| 52 Week High | $1.78 | $10.61 |
| Indicator | HUMA | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 27.57 |
| Support Level | $0.34 | N/A |
| Resistance Level | $0.46 | $8.84 |
| Average True Range (ATR) | 0.04 | 0.20 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 55.07 | 17.76 |
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.